RxDoctor Payments Data

Kim Smith-Whitley

Pediatric Hematology-Oncology · Philadelphia, PANPI 1760492359

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,188 of the $1,526 with a category attached, or 77.8%. Bristol Myers Squibb accounts for 85.6% of it on its own, with 2 other manufacturers making up the rest.

$1,526in general payments, 2019–2025

Across 6 payments — averaging $254.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$1K
  • Novartis$135
  • Pfizer$85
$1,000,348in research payments, 2019–2025

Across 19 payments — averaging $52,650 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$967K
  • Global Blood Therapeutics, Inc.$23K
  • Pfizer$11K

What the payments were for

  • Travel & lodging$1,18878%
  • Food & beverage$33822%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bristol Myers Squibb4$1,306
Novartis1$135
Pfizer1$85

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,526 in reported general payments places this provider in the 60th percentile of 139 pediatric hematology-oncology providers in Pennsylvania.

See all pediatric hematology-oncology providers in Pennsylvania

Other pediatric hematology-oncology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →